US President Donald Trump has signed an executive order attempting to restore a robust domestic manufacturing base for ...

Sino American biotech BeiGene (Nasdaq: ONC; HKEX: 06160), a global oncology company that will change its name to BeOne ...

UK-based pharma major AstraZeneca and its Japanese partner Daiichi Sankyo are moving to expand the reach of their blockbuster ...

A Seattle-based preclinical biotech comany developing novel neuroplastogens to treat neuropsychiatric and neurodegenerative ...

Shares in Danish drugmaker Novo Nordisk were 3% higher on Wednesday afternoon after the company presented its first-quarter ...

French drugmaker Ipsen (Euronext: IPN) today announced new data from two late-breaking presentations on Iqirvo (elafibranor) ...

NewLimit was founded to develop medicines that add healthy years to each human life. Initially, we thought it would take many ...

Lossmaking Danish pharma ingredients maker Xellia Pharmaceuticals said it could only survive against Chinese competition by ...

California-based Atara Biotherapeutics (Nasdaq: ATRA) revealed that the US Food and Drug Administration (FDA) has lifted the ...

Trade group the Association of the British Pharmaceutical Industry (ABPI) has spoken out against a new free trade agreement signed by the UK government with India.

The Russian government will consider registering next-in-class drugs based on data from the second phase of clinical trials ...

The US Food and Drug Administration (FDA) announced its intent to expand the use of unannounced inspections at foreign ...